4.6 Review

Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies

期刊

EXPERT OPINION ON DRUG DELIVERY
卷 15, 期 8, 页码 821-834

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2018.1502267

关键词

Aerosol devices; inhaled macromolecules; lung delivery; microcarrier; nanocarrier; nanomedicine; lipid-based systems; passive and active targeting; pulmonary pathologies

资金

  1. Medical Research Council [MR/P022758/1]
  2. MRC [MR/P022758/1] Funding Source: UKRI

向作者/读者索取更多资源

Introduction: Macromolecules with unique effects and potency are increasingly being considered for application in lung pathologies. Numerous delivery strategies for these macromolecules through the lung have been investigated to improve the targeting and overall efficacy.Areas covered: Targeting approaches from delivery devices, formulation strategies and specific targets are discussed.Expert opinion: Although macromolecules are a heterogeneous group of molecules, a number of strategies have been investigated at the macro, micro, and nanoscopic scale for the delivery of macromolecules to specific sites and cells of lung tissues. Targeted approaches are already in use at the macroscopic scale through inhalation devices and formulations, but targeting strategies at the micro and nanoscopic scale are still in the laboratory stage. The combination of controlling lung deposition and targeting after deposition, through a combination of targeting strategies could be the future direction for the treatment of lung pathologies through the pulmonary route.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据